Shuning Gai
6Patents
2h-index
25Co-inventors
43Inventor score
Filing activity: May 21, 2013 → Mar 4, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9844582B2 | Synergistic tumor treatment with extended-PK IL-2 and therapeutic agents | Human Necessities | 34 | Active |
| US10821157B2 | Glycotargeting therapeutics | Chemistry; Metallurgy | 15 | Active |
| US11666638B2 | Glycotargeting therapeutics | Chemistry; Metallurgy | 1 | Active |
| US11654188B2 | Glycotargeting therapeutics | Chemistry; Metallurgy | 1 | Active |
| US11958896B2 | Antibodies recognizing tau | Chemistry; Metallurgy | 0 | Active |
| US12162945B2 | EPHA2 antibodies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.